ReviewDiagnostics (Basel, Switzerland)2022
Tuberculous Pericarditis-Own Experiences and Recent Recommendations.
Review in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Tuberculous Pericarditis in Childhood: A Case Report and a Systematic Literature Review.Pathogens (Basel, Switzerland) · 2024Pooled it
- Diagnostic performance of third-generation sequencing for tuberculous pericarditis: a systematic review and meta-analysis protocol.BMJ open · 2026Article
- Article
- MELD 3.0 Score and Time to Discharge After Pericardiectomy: A Competing Risks Analysis in Tuberculous Constrictive Pericarditis.Journal of clinical medicine · 2026Article
- A Case Series of Tuberculous Pericarditis: Clinical Profiles and Diagnostic Challenges.Cureus · 2026Article
- Pericardial calcification in tuberculous constrictive pericarditis: a marker of chronicity unassociated with early postoperative outcomes.Quantitative imaging in medicine and surgery · 2026Article
- Machine learning algorithms for identifying tuberculous pericardial effusion: insights from a retrospective study in Vietnam.BMC medical informatics and decision making · 2026Article
- Cardiovascular Complications from Tuberculosis.Reviews in cardiovascular medicine · 2025Review
- A Silent Threat: Tuberculous Pericarditis Presenting With Early Tamponade in a Young Migrant.Cureus · 2025Article
- Clinical Characteristics and Outcomes of Patients with Constrictive Pericarditis Following Pericardiectomy: An Observational Study.JNMA; journal of the Nepal Medical Association · 2025Observational
- Fulminant Tuberculous Pericarditis Presenting as Cardiac Tamponade in an Infliximab-Treated Patient.Cureus · 2025Article
- Pericardial Effusion: Overview of Aetiology, Pathophysiology, Diagnosis, and Management.Cureus · 2025Review
- Multisystemic Tuberculosis Masquerading as Aggressive Cardiac Tumor Causing Budd-Chiari Syndrome Disseminated to the Brain Resulting in Death of a Six-Year-Old Boy.Pathogens (Basel, Switzerland) · 2025Article
- Article
- Severely calcified pericardium as post tuberculosis sequale.Oxford medical case reports · 2024Article
- Clinical Significance of Preoperative Pyrazinamide-Containing Therapy in Tuberculous Constrictive Pericarditis.Infection and drug resistance · 2024Article
- The Important Role of Preoperative D-Dimer in Constrictive Pericarditis.Therapeutics and clinical risk management · 2024Article
- A life-threatening pericardial tamponade revealing disseminated tuberculosis: A challenging medical care.Heliyon · 2023Article
- Clinical Application of theInfection and drug resistance · 2023Article
- Large Pericardial Effusion-Diagnostic and Therapeutic Options, with a Special Attention to the Role of Prolonged Pericardial Fluid Drainage.Diagnostics (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tuberculous pericarditis (TBP) accounts for 1% of all forms of tuberculosis and for 1-2% of extrapulmonary tuberculosis. In endemic regions, TBP accounts for 50-90% of effusive pericarditis; in non-endemic, it only accounts for 4%. In the absence of prompt and effective treatment, TBP can lead to very serious sequelae, such as cardiac tamponade, constrictive pericarditis, and death. Early diagnosis of TBP is a cornerstone of effective treatment. The present article summarises the authors' own experiences and highlights the current status of knowledge concerning the diagnostic and therapeutic algorithm of TBP. Special attention is drawn to new, emerging molecular methods used for confirmation of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.